Lung Diseases, Interstitial
"Lung Diseases, Interstitial" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Descriptor ID |
D017563
|
| MeSH Number(s) |
C08.381.483
|
| Concept/Terms |
Lung Diseases, Interstitial- Lung Diseases, Interstitial
- Interstitial Lung Disease
- Lung Disease, Interstitial
- Interstitial Lung Diseases
- Diffuse Parenchymal Lung Diseases
Pneumonia, Interstitial- Pneumonia, Interstitial
- Interstitial Pneumonia
- Interstitial Pneumonias
- Pneumonias, Interstitial
- Pneumonitis, Interstitial
- Interstitial Pneumonitides
- Interstitial Pneumonitis
- Pneumonitides, Interstitial
|
Below are MeSH descriptors whose meaning is more general than "Lung Diseases, Interstitial".
Below are MeSH descriptors whose meaning is more specific than "Lung Diseases, Interstitial".
This graph shows the total number of publications written about "Lung Diseases, Interstitial" by people in this website by year, and whether "Lung Diseases, Interstitial" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1994 | 1 | 0 | 1 |
| 1995 | 0 | 2 | 2 |
| 1996 | 0 | 1 | 1 |
| 1997 | 0 | 1 | 1 |
| 1998 | 1 | 1 | 2 |
| 2002 | 1 | 2 | 3 |
| 2003 | 2 | 0 | 2 |
| 2004 | 5 | 1 | 6 |
| 2005 | 2 | 3 | 5 |
| 2006 | 4 | 2 | 6 |
| 2007 | 5 | 1 | 6 |
| 2008 | 3 | 0 | 3 |
| 2009 | 3 | 1 | 4 |
| 2010 | 0 | 2 | 2 |
| 2011 | 7 | 0 | 7 |
| 2012 | 6 | 1 | 7 |
| 2013 | 4 | 0 | 4 |
| 2014 | 3 | 0 | 3 |
| 2015 | 7 | 0 | 7 |
| 2016 | 3 | 2 | 5 |
| 2017 | 4 | 0 | 4 |
| 2018 | 4 | 0 | 4 |
| 2019 | 10 | 1 | 11 |
| 2020 | 6 | 2 | 8 |
| 2021 | 8 | 0 | 8 |
| 2022 | 12 | 1 | 13 |
| 2023 | 14 | 0 | 14 |
| 2024 | 7 | 1 | 8 |
To return to the timeline,
click here.
Below are the most recent publications written about "Lung Diseases, Interstitial" by people in Profiles.
-
Characterizing interstitial lung disease in patients with psoriasis: a cross-sectional analysis in the National Institutes of Health's All of Us Research Program. Clin Exp Dermatol. 2024 Aug 22; 49(9):1083-1084.
-
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Care Res (Hoboken). 2024 08; 76(8):1051-1069.
-
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Rheumatol. 2024 Aug; 76(8):1201-1213.
-
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Screening and Monitoring of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Care Res (Hoboken). 2024 08; 76(8):1070-1082.
-
2023 American College of Rheumatology (ACR)/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases. Arthritis Rheumatol. 2024 Aug; 76(8):1182-1200.
-
Proteomic Biomarkers of Quantitative Interstitial Abnormalities in COPDGene and CARDIA Lung Study. Am J Respir Crit Care Med. 2024 05 01; 209(9):1091-1100.
-
Risk of 30-Day All-Cause Readmission in Interstitial Lung Disease Patients after COVID-19: National-Level Data. Ann Am Thorac Soc. 2024 Mar; 21(3):428-437.
-
Short peripheral blood leukocyte telomere length in rheumatoid arthritis-interstitial lung disease. Thorax. 2024 01 18; 79(2):182-185.
-
Tuftelin1 drives experimental pulmonary fibrosis progression by facilitating stress fiber assembly. Respir Res. 2023 Dec 17; 24(1):318.
-
Peptidylarginine deiminase 2 citrullinates MZB1 and promotes the secretion of IgM and IgA. Front Immunol. 2023; 14:1290585.